Navigation Links
SJF Ventures Completes Oversubscribed Series A Round for BioSurplus

DURHAM, N.C., and SAN DIEGO, July 17, 2012 /PRNewswire/ -- BioSurplus Inc., a leading provider of equipment management services and pre-owned laboratory instruments, announces the close of an oversubscribed Series A financing round with new funding from SJF Ventures.  The company raised a total of $2.4 million following a May investment from KI Investment Holdings.

With these investments, BioSurplus has expanded in Boston more quickly than anticipated.  The company will hold its first Boston auction of like-new used laboratory equipment from one of the most respected area distributors.  The equipment will be on display Aug. 13-14 from 10 a.m. to 6 p.m. at 56 Roland St. in Boston, with the online auction being held Aug. 15-22.  In addition, BioSurplus seeks qualified candidates to fill five new Boston positions in operations, sales, business development and tech support.

"SJF Ventures is pleased to support BioSurplus' growth and Boston expansion," said David Griest, Managing Director at SJF Ventures.  "The company is a market leader in an emerging sector of asset recovery, which fills a strategic position in our portfolio.  As the first investment of our third fund, BioSurplus aligns perfectly with our focus on capital efficient, growth stage companies offering proven solutions."

"Our oversubscribed Series A round and successful regional expansion illustrates that BioSurplus fills a very unique and underserved market need for used and refurbished lab equipment and related services," said Preston "Cinco" Plumb, President and CEO.  "We are delighted to partner with SJF Ventures and KI Investment Holdings, whose recent investments have put us months ahead of schedule for our Boston expansion and have positioned us for future growth."

About BioSurplus

Since 2002, BioSurplus has assembled a team of scientific experts to pioneer leading edge solutions for every stage of the lab equipment lifecycle.  From providing a website of dynamic inventory and online auctions, to developing software solutions that allow clients to manage their own equipment, to offering turnkey solutions for selling surplus assets, BioSurplus is dedicated to maximizing the value and use of laboratory equipment for its customers.  To this end, it has become a leading supplier of pre-owned laboratory instruments and equipment management services.

BioSurplus is headquartered in San Diego and has large showrooms in San Diego, the San Francisco Bay Area, Boston and Korea.  BioSurplus offers services nationally and sells equipment worldwide.  For more information, please visit the corporate website at

About SJF Ventures

SJF Ventures is a venture capital fund with offices in Durham, N.C., New York and San Francisco.  SJF has a 13-year successful record of assisting visionary and talented management teams in building industry-leading firms.  SJF provides strong expertise and networks in the cleantech, sustainability and technology enhanced services sectors; including particular experience in asset recovery, reuse and recycling with portfolio companies including eRecyclingCorps, Optoro, Salvage Direct, and Intechra.  For more information, visit

About KI Investment Holdings

KI Investment Holdings, LLC is an innovative investment firm, providing capital and expertise towards the goal of being instrumental in the long-term success of its portfolio companies.  For more information, visit

SOURCE BioSurplus
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Files Defamation Lawsuit
2. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
3. Pappas Ventures Names Pat Gage to Scientific Advisory Board
4. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
5. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
6. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
7. CryoLife Completes Acquisition of Hemosphere
8. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
9. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
10. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
11. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
(Date:11/24/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Piper ... public is welcome to participate in the conference ... Jaffray Annual Healthcare ConferencePresenter:  , Ron Squarer, Chief ... Eastern Time Webcast: , ...
(Date:11/24/2015)... , Nov. 24, 2015  DILON Diagnostics and ... signed an agreement for DILON to distribute GE,s Discovery ... the globe. The signing of this distribution agreement will provide ... Molecular Breast Imaging system and is considered an initial ... better healthcare solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... is offering lower prices in an early celebration of the early holiday shopping ... price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
Breaking Medicine News(10 mins):